Tucatinib in der Therapie des HER2-positiven Mammakarzinoms: Hohe Aktivität auch bei Hirnmetastasen

Maggie Banys-Paluchowski; Natalia Krawczyk

doi:10.1007/s00761-020-00828-0

Tucatinib in der Therapie des HER2-positiven Mammakarzinoms: Hohe Aktivität auch bei Hirnmetastasen

Translated title of the contribution: Tucatinib in the treatment of HER2-positive breast cancer: Highly effective in patients with brain metastases

Maggie Banys-Paluchowski^*, Natalia Krawczyk

^*Corresponding author for this work

Clinic of Gynecology and Obstetrics

University of Düsseldorf

Translated title of the contribution	Tucatinib in the treatment of HER2-positive breast cancer: Highly effective in patients with brain metastases
Original language	German
Journal	Onkologe
Volume	26
Issue number	10
Pages (from-to)	966-969
Number of pages	4
ISSN	0947-8965
DOIs	https://doi.org/10.1007/s00761-020-00828-0
Publication status	Published - 01.10.2020

Research Areas and Centers

Research Area: Luebeck Integrated Oncology Network (LION)
Centers: University Cancer Center Schleswig-Holstein (UCCSH)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00761-020-00828-0

Cite this

@article{478d8562a6934a869cf9f9e669b65ad6,

title = "Tucatinib in der Therapie des HER2-positiven Mammakarzinoms: Hohe Aktivit{\"a}t auch bei Hirnmetastasen",

author = "Maggie Banys-Paluchowski and Natalia Krawczyk",

year = "2020",

month = oct,

day = "1",

doi = "10.1007/s00761-020-00828-0",

language = "Deutsch",

volume = "26",

pages = "966--969",

journal = "Onkologe",

issn = "0947-8965",

number = "10",

}

TY - JOUR

T1 - Tucatinib in der Therapie des HER2-positiven Mammakarzinoms: Hohe Aktivität auch bei Hirnmetastasen

AU - Banys-Paluchowski, Maggie

AU - Krawczyk, Natalia

PY - 2020/10/1

Y1 - 2020/10/1

UR - http://www.scopus.com/inward/record.url?scp=85089107976&partnerID=8YFLogxK

U2 - 10.1007/s00761-020-00828-0

DO - 10.1007/s00761-020-00828-0

M3 - Zeitschriftenaufsätze

AN - SCOPUS:85089107976

SN - 0947-8965

VL - 26

SP - 966

EP - 969

JO - Onkologe

JF - Onkologe

IS - 10

ER -

Tucatinib in der Therapie des HER2-positiven Mammakarzinoms: Hohe Aktivität auch bei Hirnmetastasen

Research Areas and Centers

UN SDGs

Access to Document

Other files and links

Cite this